LGT Financial Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.64K Hold
84
0.04% 165
2026
Q1
$7.24K Sell
84
-32
-28% -$2.87K 0.04% 169
2025
Q4
$10.1K Hold
116
0.06% 133
2025
Q3
$6.64K Buy
116
+40
+53% +$2.3K 0.01% 274
2025
Q2
$4.49K Hold
76
0.01% 302
2025
Q1
$5.56K Sell
76
-474
-86% -$39.2K 0.02% 216
2024
Q4
$45.5K Hold
550
0.1% 161
2024
Q3
$39.3K Sell
550
-150
-21% -$10.6K 0.1% 162
2024
Q2
$47.9K Sell
700
-996
-59% -$59.5K 0.1% 166
2024
Q1
$91K Buy
1,696
+1,645
+3,225% +$88.4K 0.11% 184
2023
Q4
$2.72K Sell
51
-33
-39% -$1.61K ﹤0.01% 758
2023
Q3
$4.17K Buy
+84
New +$4.7K 0.01% 662

Other funds holding GMED

LGT Financial Advisors's GMED Position: Q2 2026 in Review

LGT Financial Advisors held its Globus Medical (GMED) position steady in Q2 2026 at 84 shares worth $6.64K. The position accounts for 0.04% of the portfolio, ranked #165.

LGT Financial Advisors first reported a position in GMED in Q3 2023 and has held it in 12 quarters since. The position peaked at $91K in Q1 2024. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • LGT Financial Advisors held 84 shares of Globus Medical worth $6.64K as of Q2 2026.
  • LGT Financial Advisors left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up 0.04% of LGT Financial Advisors's portfolio in Q2 2026, its #165 holding.
  • LGT Financial Advisors first reported a position in Globus Medical in Q3 2023 and has held it in 12 quarters since.
  • LGT Financial Advisors's Globus Medical position peaked at $91K in Q1 2024.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on LGT Financial Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.